Tuesday, May 24 2022
download app
download appDOWNLOAD OUR APP
download google-play
download app-store
Emilija Berzanskaite
share
17th November 2021
Covid-19

Ombudsman sides with EMA’s refusal to grant public access to documents relating to the manufacturing of mRNA vaccines against COVID-19

The European Ombudsman has adopted a Decision on the European Medicines Agency's (EMA) refusal of public access to documents relating to the manufacturing of mRNA vaccines against COVID-19, concluding that there was no maladministration by the EMA because detailed information on the manufacturing process is commercial information, and no overriding public interest exists for its disclosure.

In December 2020 and January 2021 respectively, EMA recommended granting conditional marketing authorisations for two ‘messenger-RNA’ vaccines against COVID-19, namely, Comirnaty (BioNTech/Pfizer) and COVID-19 vaccine (Moderna), which were ultimately authorised by the European Commission. 

The case at hand concerns a request for public a

×

Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.

Cookies